Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia.

midregional proadrenomedullin (MR-proADM) is a prognostic biomarker in patients with community-acquired pneumonia (CAP). We sought to confirm whether MR-proADM added to Pneumonia Severity Index (PSI) improves the potential prognostic value of PSI alone, and tested to what extent this combination cou...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Susana Gordo-Remartínez, María Calderón-Moreno, Juan Fernández-Herranz, Ana Castuera-Gil, Mar Gallego-Alonso-Colmenares, Carolina Puertas-López, José A Nuevo-González, Domingo Sánchez-Sendín, Mercedes García-Gámiz, José A Sevillano-Fernández, Luis A Álvarez-Sala, Juan A Andueza-Lillo, José M de Miguel-Yanes
Materialtyp: Artigo
Språk:Inglês
Publicerad: Public Library of Science (PLoS) 2015-01-01
Serie:PLoS ONE
Länkar:http://europepmc.org/articles/PMC4452655?pdf=render
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk